Edward Brian Butler
Overview
Explore the profile of Edward Brian Butler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
153
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martino A, Terracciano R, Milicevic B, Milosevic M, Simic V, Fallon B, et al.
Pharmaceutics
. 2024 Aug;
16(8).
PMID: 39204354
Blood vessels are essential for maintaining tumor growth, progression, and metastasis, yet the tumor vasculature is under a constant state of remodeling. Since the tumor vasculature is an attractive therapeutic...
2.
Tran K, Schefler A, Chevli N, Hasegawa N, Ivey F, Olek D, et al.
Brachytherapy
. 2024 Jun;
23(5):604-609.
PMID: 38851918
Purpose: Eye plaque brachytherapy (EPBT) is the most common treatment for uveal melanoma with high local control rates of 95-100%. When local recurrences occur following EPBT, salvage options include enucleation,...
3.
Haque W, Butler E, Teh B
Curr Oncol
. 2024 Mar;
31(3):1588-1599.
PMID: 38534954
Breast cancer is diagnosed in nearly 3 million people worldwide. Radiation therapy is an integral component of disease management for patients with breast cancer, and is used after breast-conserving surgery...
4.
Hasegawa N, Teh B, Tran K, Ivey F, Olek D, Pino R, et al.
Am J Ophthalmol
. 2023 Dec;
260:49-59.
PMID: 38081570
Purpose: To associate clinical factors and radiation doses delivered by iodine-125 plaque brachytherapy to visual outcomes and development of radiation-induced ocular complications in patients with uveal melanoma in the era...
5.
Andring L, Teh B, Butler E, Farach A
Chin Clin Oncol
. 2023 Jul;
12(3):26.
PMID: 37417290
Background And Objective: Prostate cancer is the second most common cause of cancer in men worldwide. A significant proportion of patients will develop biochemical failure after definitive radiotherapy and an...
6.
Haque W, Verma V, Schwartz M, Lim B, Mangalampalli N, Butler E, et al.
Clin Breast Cancer
. 2022 Feb;
22(5):e691-e699.
PMID: 35193807
Introduction: Neoadjuvant chemotherapy (NAC) for breast cance has not been well studied for metaplastic breast cancer (MBC), a rare but aggressive type of breast cancer. Materials And Methods: The National...
7.
Liu H, Viswanath D, Pesaresi F, Xu Y, Zhang L, Di Trani N, et al.
Int J Radiat Oncol Biol Phys
. 2020 Aug;
110(2):492-506.
PMID: 32768562
Purpose: Mounting evidence demonstrates that combining radiation therapy (RT) with immunotherapy can reduce tumor burden in a subset of patients. However, conventional systemic delivery of immunotherapeutics is often associated with...
8.
Scranton R, Sadrameli S, Butler E, Farach A, Wang H, Teh B, et al.
Pract Radiat Oncol
. 2019 Dec;
10(2):133-137.
PMID: 31790826
No abstract available.
9.
Haque W, Verma V, Suzanne Klimberg V, Nangia J, Schwartz M, Butler E, et al.
Breast J
. 2019 Oct;
26(4):653-660.
PMID: 31578797
Breast adenomyoepithelioma (AME) is a rare tumor with the published literature mainly in the form of case reports. Thus, there is currently only limited published data to guide evidence-based management....
10.
Vakil H, Tran L, Lewis G, Cykowski M, Butler E, Teh B
Rep Pract Oncol Radiother
. 2019 Sep;
24(6):528-532.
PMID: 31516399
Meningiomas are the most common type of benign tumor found in the brain and are typically benign, slow-growing lesions. The current standard of care consists of surgical resection and subsequent...